PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
February 1, 2026Journal of Advanced ResearchOpen Access

Biomimetic and personalized nanovaccines in cancer immunotherapy: Design innovations, translational challenges, and future directions

View Full Paper
Ask AI
Bookmark
Share

Authors

SXSuling XuHYHaitao YangBMBoris Minev

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Xu et al. (2026) studied this question.

synapsesocial.com/papers/6a08991cdf3db8739810a6c7https://doi.org/10.1016/j.jare.2026.01.070
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy2024 · 120 citations
  2. 2Nano drug delivery systems for advanced immune checkpoint blockade therapy2025 · 123 citations
  3. 3Dendritic Cell-Derived Exosomes in Cancer Immunotherapy2023 · 69 citations
  4. 4A functional identification platform reveals frequent, spontaneous neoantigen-specific T cell responses in patients with cancer2024 · 22 citations
  5. 5Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy2023 · 111 citations